Mammary tumours in dogs

Irish Veterinary Journal

Volumn 62, Issue 1, 2009, Pages 50-56

  Polton, Gerry ^a  

^a NORTH DOWNS SPECIALIST REFERRALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 58649120474     PISSN: 03680762     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Benjamin SA, Lee AC and Saunders WJ (1999) Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles. Veterinary Pathology 36, 423-436.
2. Chang SC, Chang CC, Chang TJ et al. (2005) Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002). Journal of the American Veterinary Medical Association 227, 1625-1629.
3. Eisen A, Lubinski J, Klijn J et al. (2008) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. Journal of Clinical Oncology 23, 7491-7496.
4. Gilbertson SR, Kurzman ID, Zachrau RE et al. (1983) Canine mammary epithelial neoplasms: biological implications of morphologic characteristics assessed in 232 dogs. Veterinary Pathology 20, 127-142.
5. Karayannopoulou M, Kaldrymidou E, Constantinidis TC et al. (2001) Adjuvant post-operative chemotherapy in bitches with mammary cancer. Journal of Veterinary Medicine A: Physiology, Pathology and Clinical Medicine 48, 85-96.
6. Karayannopoulou M, Kaldrymidou E, Constantinidis TC et al. (2005) Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. Journal of Comparative Pathology 133 1-7.
7. Kurzman ID, Gilbertson SR (1986) Prognostic factors in canine mammary tumors. Seminars in Veterinary Medicine and Surgery (Small Animal) 1, 25-32.
8. Martin de las Mulas J Millan Y, Dios R et al. (2005) A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease free period in mammary tumors of the dog. Veterinary Pathology 42, 200-212.
9. Millanta F, Calandrella M, Bari G et al. (2005) Comparison of steroid receptor expression in normal, dysplastic and neoplastic canine and feline mammary tissues. Research in Veterinary Science 79, 225-232.
10. Moe L (2001) Population-based incidence of mammary tumors in some dog breeds. Journal of Reproduction and Fertility 57, 439-43.
11. Perez-Alenza MD, Pena L, del Castillo N et al. (2000) Factors influencing the incidence and prognosis of canine mammary tumours. Journal of Small Animal Practice 41, 287-291
12. Queiroga FL, Perez-Alenza MD, Silvan G et al. (2005) Role of steroid hormones and prolactin in canine mammary cancer. Journal of Steroid Biochemistry and Molecular Biology 94, 181-187.
13. Queiroga FL, Perez-Alenza MD, Silvan G et al. (2008) Serum and tissular prolactin levels in canines with malignant mammary tumours by ELISA assay: clinical and prognostic implications. Proceedings of 18th ECVIM-CA Congress, 4-6 September 2008, Ghent, Belgium p 189.
14. Rivera P, Haggstrom J, Nyman H et al. (2007) Efficacy and toxicity of a new formulation of paclitaxel (Paclical® vet) in a phase 1+11 study for the treatment of malignant tumours in dogs. Proceedings of the 17th ECVIM-CA Congress, 13-15 September 2007, Budapest. Hungary. Veterinary and Comparative Oncology 6, 69.
15. Schneider R, Dorn CR and Taylor DON (1969) Factors influencing canine mammary cancer development and postsurgical survival. Journal of the National Cancer Institute 43, 1249-1261.